Financials
- Market Capitalization 286.03 M
- Employee 293
- Founded 2000
- CEO N/A
- Website www.macrogenics.com
- Headquarter Delaware, United States
- FIGI BBG000BM2SF8
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3355 | INDP Indaptus Therapeutics, Inc. - Common Stock | 2.63 USD | 0.00% | -1.13% | -27.35% | +38.42% | 297.83 M USD | ||
| 3360 | NMRA Neumora Therapeutics, Inc. - Common Stock | 1.60 USD | -4.76% | -4.19% | +72.04% | +24.03% | 296.45 M USD | ||
| 3390 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.73 USD | -2.36% | -4.60% | +8.43% | +54.13% | 285.21 M USD | ||
| 3394 | TTRX Turn Therapeutics Inc. - Common Stock | 9.47 USD | +0.32% | +19.27% | +53.24% | -5.30% | 282.09 M USD |
Frequently asked questions about MacroGenics, Inc. - Common Stock
What is the MacroGenics, Inc. - Common Stock stock price today?
The current price of MacroGenics, Inc. - Common Stock (MGNX) is 4.5. Over the past 24 hours, the stock has changed by +3.93%. Follow the MGNX chart for real-time price dynamics.
What is the stock ticker of MacroGenics, Inc. - Common Stock?
MacroGenics, Inc. - Common Stock trades under the ticker MGNX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MacroGenics, Inc. - Common Stock stock going up?
MGNX has changed by -2.17% over the last week, +13.64% over the last month, and +186.62% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was MacroGenics, Inc. - Common Stock net income for the last quarter?
MacroGenics, Inc. - Common Stock reported net income of -36.77 M for the last quarter. The previous quarter showed -14.15 M, which means net income changed by -159.80%.
How many employees does MacroGenics, Inc. - Common Stock have?
As of the latest available data, MacroGenics, Inc. - Common Stock has 293 employees. Workforce size can provide additional context about the company's scale and operations.
What is MacroGenics, Inc. - Common Stock EBITDA?
MacroGenics, Inc. - Common Stock EBITDA is -31.75 M, and its EBITDA margin is -152.84%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy MacroGenics, Inc. - Common Stock stock?
You can buy MacroGenics, Inc. - Common Stock (MGNX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MacroGenics, Inc. - Common Stock stock?
Investing in MacroGenics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MGNX chart and related analysis on metatrader.com as part of your research.